Build an AIoT Predictive Line: Pharma Factory Digital Twin Guide Paperless manufacturing was phase one. Predictive is phase two — and most pharma factories haven’t started the transition. At AUTOMA+ 2026, the conversation shifted from “digitize your records” to “connect every sensor, build a digital twin, and let AI flag deviations before they become batch failures.” The technology exists today.
Key Takeaways
Build an AIoT Predictive Line: Pharma Factory Digital Twin Guide Paperless manufacturing was phase one.
At AUTOMA+ 2026, the conversation shifted from “digitize your records” to “connect every sensor, build a digital twin, and let AI flag deviations before they become batch failures.” The technology exists today.
The Paperless Trap: Why Digitized Records Don’t Prevent Failures Most pharma manufacturers have already gone paperless — electronic batch records, digital signatures, audit trails stored in validated systems.
Bottom Line
Build AIoT Predictive Line: Pharma Digital Twin Guide is a signal worth watching in 2026. If you're building or securing infrastructure, keep an eye on this trend.
Read the full analysis on Susiloharjo.
